In the tissue engineering industry there is a lot of discussion around the complexities of seeding adherent cells, the best modes for generating vascularized scaffolds, the challenges associated with the packaging and transport of tissue-engineered medical products (TEMPs), and how to get your product to market quickly.
Working at the intersection of tissue engineering, stem cell biology, and optical imaging, scientists at the University of Washington created an effective way to grow heart tissue in vitro.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
Wearable device helps frogs regrow amputated limbs.
Researchers used cells to build and test a disc replacement with the strength and flex of a native disc, paving the way for human use.
Researchers used cells to build and test a disc replacement with the strength and flex of a native disc, paving the way for human use.
Engineers at the Georgia Institute of Technology have figured out a cell-based approach to healing damaged muscle that could offer a more efficient method than those currently used.
Researchers moved closer to solving problems with treating heart disease by developing ways to build tissues and parts of a human heart using human stem cells.
The first viable prototype of an artificial lung offers new hope for the more than one thousand people awaiting lung transplants across the United States.
The first viable prototype of an artificial lung offers new hope for the more than one thousand people awaiting lung transplants across the United States.
Researchers from the University of Connecticut have fabricated a new biodegradable composite from strands of silk fibroin, the foundational element of spider and moth silk, to replace the metal plates and screws currently used by orthopedists to help repair broken load-bearing bones.
An international team has grown up to 20,000 vascularized liver buds at a time and reversed liver failure in 60 percent of mice that received the implants.
An international team has grown up to 20,000 vascularized liver buds at a time and reversed liver failure in 60 percent of mice that received the implants.
Joseph Wu Director of the Stanford Cardiovascular Institute and Professor of Medicine and Radiology at Stanford University, discusses the rise of engineered cell and tissue products for use in patients. While these products are now technically advanced and better suited for the clinic, there continues to be issues around patient safety that need to be monitored and mitigated for routine use and mass production.
Northeastern University's Micropower and Nanoengineering Laboratory's new technique in origami folding to build 3D liver tissue constructs from flat sheets could mimic human organs and reduce time, expense, and testing needed to commercialize new pharmaceuticals.